Volume 10, Number 10—October 2004
Virus-specific RNA and Antibody from Convalescent-phase SARS Patients Discharged from Hospital
|Patient no.||Age||Sex||Ethnicity||Occupation||Specimens provided||Viral loadb (copies/mL)||History of ICU admission||Required supplemental oxygen||Peak LDH U/L||Concurrent illness|
|3||43||Male||Malay||Unemployed||Wk 5c||Wk 5 ( 33.9 x 103)||No||No||299||Diabetes mellitus type 2 Steroid use|
|16||33||Female||Indian||Domestic maid||Wks 4,c 5,6||Wk 4 (37.1 x 103)||No||Yes, I/N||1,127||None|
|35||17||Male||Chinese||Student||Wk 9c||Wk 9 (1.73 x 103)||No||No||615||None|
|51||30||Female||Filipino||Healthcare worker||Wks 5,c 6c||Wk 5 (2 x 103) Wk 6 (1.64 x 103)||No||No||1,065||None|
|62||35||Male||Chinese||Diver||Wk 5c||Wk 5 (7.76 x 103)||No||Yes, I/N||952||None|
aSARS-CoV, severe acute respiratory syndrome–associated coronavirus; ICU, intensive care unit; LDH, lactate dehydrogenase; I/N, intranasal oxygen.
bRT-PCR was performed by using the RealArt HPA-coronavirus RT-PCR kit (Artus Gmbh, Hamburg, Germany) on the Roche Lightcycler. Viral load was determined for each mL of stool sample.
cPositive RT-PCR results for SARS-CoV.
1These authors contributed equally to this paper.
- Page created: April 11, 2011
- Page last updated: April 11, 2011
- Page last reviewed: April 11, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)